version-1-1-1024x485-min

Consumers Who Have Used Zantac® And Are Now Suffering From A Stomach (Gastric) Cancer Diagnosis Are Urged To Get a Free Case Evaluation For Justice and Compensation

Consumers Who Have Used Zantac® And Are Now Suffering From A Stomach (Gastric) Cancer Diagnosis Are Urged To Get a Free Case Evaluation For Justice and Compensation

Some of the stomach (gastric) cancer symptoms that consumers of Zantac® (aka ranitidine®) consumers should be wary of may include:

  • Poor appetite
  • Weight loss (without trying)
  • Abdominal (belly) pain
  • Vague discomfort in the abdomen, usually above the navel
  • Feeling full after eating only a small meal
  • Heartburn or indigestion
  • Nausea
  • Vomiting, with or without blood

FREE CLAIM REVIEW

Did you take any of the following Medications? (Check all that Apply)(Required)
To qualify, Please Check All that Apply(Required)
Name(Required)

By clicking the "Free Case Review" button, I consent to receive recurring auto dialed and/or pre-recorded telemarketing calls and/or text messages from Shield Legal LP or our partners in order to discuss my legal options and at the telephone number I provided. I also consent to the Shield Legal LP Privacy Policy and Terms of Use. I understand that I may receive a call even if my telephone number is listed on a Do Not Call list and that my consent is not a requirement of purchase. I understand that my telephone company may impose charges on me for these contacts and that I can revoke this consent at any time. For SMS campaigns: Text STOP to cancel and HELP for help. Msg & data rates may apply. Recurring msgs up to 27 msgs per month.

100% confidential Case Evaluations

Answer a few basic questions to get started

Receive a confidential case evaluation

Have an individual claim filed for compensation

What Zantac® (aka ranitidine®) Consumers Must Know About Its Link to Stomach (Gastric) Cancer?

Due to detected levels of a probable human carcinogen in ranitidine® medications, taking Zantac® may increase the risk of developing stomach (gastric) cancer.

Zantac® (aka ranitidine®) lawyers stipulate that people must satisfy several conditions to potentially qualify for a lawsuit–these include proven Zantac® (aka ranitidine®) use plus a stomach (gastric) cancer diagnosis and a connection between the stomach (gastric) cancer diagnosis and Zantac® (aka ranitidine®) .

Only a Shield Legal Network lawyer can properly evaluate a claim, and they can help gather medical records and evidence to build a case.

    • Brand name Zantac® (aka ranitidine®) use. Potential claimants have to prove they took the brand name Zantac® made with ranitidine®–or proof of prescription–for at least one year before being diagnosed with stomach (gastric) cancer.
    • Demonstrate a stomach (gastric) cancer diagnosis. The main injury claimed in Zantac® and ranitidine® lawsuits is cancer–with potential claimants having to have a diagnosis of stomach (gastric) cancer.
  • Connection between stomach (gastric) cancer diagnosis and Zantac®. Taking higher medication doses can help prove the connection–the length of time someone has used the drug also affects the case.

Those with stomach (gastric) cancer and a history of taking Zantac® can file a legal claim against ranitidine® manufacturers.

CLICK HERE FOR A FREE LEGAL CASE REVIEW

Billions in profits made on unsafe Medication

How does Zantac® (aka ranitidine®) cause stomach (gastric) cancer?

Glaxo Holdings Ltd® (aka GSK® or GlaxoSmithKline®) created and sold Zantac® beginning in 1983 to reduce excess acid produced in stomach cells.

It was first approved for short-term use only by the Federal Drug Administration (FDA) for its potential to cause stomach (gastric) cancer if prescribed in long-term use–however, Zantac® began being marketed for long-term maintenance use.

Since over-the-counter Zantac® (aka ranitidine®) contains high levels of the potentially dangerous chemical N-nitrosodimethylamine (NDMA), it has potentially been linked to several types of lifelong cancers–including stomach (gastric) cancer.

  • The FDA advises the public to not ingest more than 96 nanograms of NDMA daily. 
  • Although food and water can both be contaminated with NDMA, the known levels of the chemical aren’t enough to cause actual harm.
  • One 150mg tablet of ranitidine showed more than 47,000 nanograms of NDMA in urine samples tested.

We believe that these stomach (gastric) cancer victims should get the compensation and justice they deserve by addressing the makers of Zantac® (aka ranitidine®) in a court of law. 

Zantac® and Stomach (Gastric) Cancer in the News

2021

One recent human study published in the British Medical Journal (BMJ) examined the potential relationship between taking blood pressure medications contaminated with NDMA and stomach (gastric) cancer.

2020

On April 1, 2020, the U.S. Food and Drug Administration (FDA) asked that all ranitidine medicines, including the medicine commonly known as Zantac, be taken off the market due to the risk of causing stomach (gastric) cancer.

2016

In 2016, researchers found that healthy men and women who took a normal dose of the heartburn medicine ranitidine, often known by the brand name Zantac, had extremely high levels of a chemical known as NDMA, a probable stomach (gastric) cancer-causing substance.

100% FREE CASE EVALUATION. SEE IF YOU QUALIFY TODAY!

CLICK HERE FOR A FREE LEGAL CASE REVIEW

Please seek the advice of a medical professional before making health care decisions. This advertisement is not associated with a Zantac®, Sanofi®, Zantac's® generic manufacturers, or any government agency.